Physician profile
Thomas Spanarkel
NPI 1831772565
$840.91
in general payments reported to CMS, 2019-2025
10 companies · $727 in 2025
The $727 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.75 · 2023: $45.45 · 2024: $43.74 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $393 · Food and Beverage: $234 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $392.58 |
| Food and Beverage | $233.59 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $432.58 | 2025 | Inspire |
| Harmony Biosciences LLC | $143.73 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $90.00 | 2025 | |
| Lilly USA, LLC | $41.53 | 2025 | Zepbound |
| Radius Health, INC. | $25.16 | 2023 | |
| Vapotherm INC | $24.75 | 2022 | |
| Resmed Corp | $23.09 | 2025 | |
| Axsome Therapeutics, INC. | $21.75 | 2025 | Sunosi |
| Eisai INC. | $20.29 | 2023 | |
| Philips North America LLC | $18.03 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Spanarkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.